Please visit the Barker Lab site here.
CDC Info on Zika
- Zika Cases in the United States
- Congenital Zika Syndrome and Other Birth Defects
- Clinical Considerations for Pregnant Women with Possible Zika Virus Infection | Zika Virus | CDC
- Testing for Zika
- Preventing Zika
- How Zika Spreads
- Zika Symptoms and Complications
- Protecting Workers from Zika
- Work outdoors? Protect yourself!
- Know before you go!
Zika virus Articles:
- Comment on "Evaluating potential associations between prior maternal yellow fever vaccination and protection against infant adverse outcomes following Zika virus antenatal exposure"
- Human scFv antibodies selected by phage display technology exhibit distinct Zika virus binding profiles and minimal cross-reactivity with dengue virus serotype 2
- Response to Comment on 'Evaluating potential associations between prior maternal yellow fever vaccination and protection against infant adverse outcomes following Zika virus antenatal exposure'
- PKR condensation at viral replication complexes initiates its activation
- Correction: The first trimester human placenta responds to Zika virus infection inducing an interferon (IFN) and antiviral interferon stimulated gene (ISG) response
- Emerging evidences in the pathogenesis and therapeutic interventions for Zika virus infection
- Protein Large Language Models Can Predict <em>Flavivirus</em> Protease Target Specificity
- Triple Burden in the Democratic Republic of Congo: Climate Change, Armed Conflict, and the Silent Spread of Arboviruses. A Narrative Review
- Co-circulation of multiple arboviruses in acute febrile patients in Yunnan, China, identified by metagenomic sequencing
- Comparative analysis of manufacturability and binding of various bispecific antibody architectures
Latest on Zika virus
- Comment on "Evaluating potential associations between prior maternal yellow fever vaccination and protection against infant adverse outcomes following Zika virus antenatal exposure"
- Response to Comment on 'Evaluating potential associations between prior maternal yellow fever vaccination and protection against infant adverse outcomes following Zika virus antenatal exposure'
- Human scFv antibodies selected by phage display technology exhibit distinct Zika virus binding profiles and minimal cross-reactivity with dengue virus serotype 2
- Correction: The first trimester human placenta responds to Zika virus infection inducing an interferon (IFN) and antiviral interferon stimulated gene (ISG) response
- Emerging evidences in the pathogenesis and therapeutic interventions for Zika virus infection
Latest on dengue virus
- "Exploring vulnerabilities: A mixed-method Transdisciplinary Study of Dengue and Diarrhea in Peru"
- Towards an integrated model for dengue management: a scoping review
- Pediatric dengue in Buenos Aires during the 2024 outbreak: clinical presentation, laboratory findings, viral load, and preexisting immunity
- Profiles of stress hormones in relation to DENV serotypes among dengue-positive patients
- Human scFv antibodies selected by phage display technology exhibit distinct Zika virus binding profiles and minimal cross-reactivity with dengue virus serotype 2